In CLL, malignant B cells benefit from BTK-mediated pro-survival signals that are triggered by tonic patterns of BCR engagement, e.g., constantly (auto)antigen-driven or autonomously by BCR autoreactivity [8]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.